Reminder we are holding a Capital Markets Day tomorrow at 9.30 am - 12.00 pm. 🧑Chaired by our #CEO 🔬 Insights into the business 📈 Human challenge trials & the growing market 🗣️ Guest speakers, including @p_openshaw ❓ Q&A with management Register: stream.brrmedia.co.uk/broadc…

Our #CEO caught up with @BRR_Media to discuss the name change from @OpenOrphan to hVIVO plc. Learn more on why #hVIVO made this strategic business decision. youtu.be/yUHCabwf2UA Our ticker has changed to #HVO Follow👉@hVIVO_UK to keep up to date!

Yesterday was a great day at the @vaccinenation 2022 #Europe event, held in the beautiful city of #Barcelona. Our #CFO presented "Utilising human challenge models to advance vaccine development" We are located at stand 67, come and join us! 👋 #hVIVO #HVO

We will be attending next week's World Vaccine Congress in #Barcelona. Stop by stand #67 to learn more about our challenge models, lab services & Vaccine Studies. Our #CSO will be presenting during the event & look forward to seeing our industry colleagues #WVC2022 #WVCEurope

We are delighted to be attending the @OptionsXi #Influenza & @IsirvEpi 12th RSV #International Symposium events on the 26 September - 2 October 2022. Our #hVIVO team look forward to connecting with our industry colleagues & presenting our #scientific posters. #ChallengeModels

Following our recent contract announcement, #hVIVO featured in @InformaConnect, the article highlights the growing demand in #influenza human challenge studies. Read full article below: informaconnect.com/rise-to-t… #hVIVO #flu #pharmanews #ORPH

Our #hLab 👨‍🔬provides high quality data outputs to enable clients to arrive at a proof of concept, or to make a breakthrough discovery in the #pathology & possible treatment of #diseases with unmet #medical needs. Learn more: hvivo.com/laboratory-service… #hVIVO #lab #virology

Our Senior Director of Clinical Science catches up with @brr_mediauk to discuss hVIVO’s contract with a #BigPharma client. Alex discusses the significance of #influenza research & #hVIVO’s role in this study. Watch here: youtu.be/xpTzf5J3NZQ

The @PneumagenLtd announcement on the phase 2 proof of concept study using @hVIVO_UK's #influenza human challenge trial featured in @Labiotech_eu. 📍This study will be taking place at our state-of-the-art #London facilities. ✍️@jimcornall labiotech.eu/trends-news/pne… #hvivo

Doubtful about the benefits of a human challenge study? 🧐Check out how our client, an #EU #biotech, had a breakthrough designation for their #vaccine candidate using #RSV human challenge study data. This clinical trial was designed & managed by #hVIVO. hvivo.com/wp-content/uploads…

We are delighted to share the published @Merck paper on the results of their study, performed at @hVIVO_UK. This was co-written by our #hVIVO's colleagues. Read full paper below: link.springer.com/article/10… #merck #cough

Last week our #hVIVO team attended the @WhiteHouse #Summit on "The Future of COVID-19 Vaccines". Featuring great aspirational discussions between #Pharma industry leaders, researchers, government officials. We are keeping up to date on the latest #COVID news. #Omicron #Pandemic

A reminder that our VP of Regulatory Affairs, Bruno Speder will be presenting "How regulators view Human Challenge Trial results" at a #hVIVO sponsored #webinar hosted by @TOPRANEWS on 21 June 2022. Register below: topra.org/TOPRA/TOPRA_Member… #regulatoryaffairs #challengetrials

Check out our Director of Clinical Science Robin Rogiers presenting the at the @clubphase1 in #Paris. The team enjoyed attending the conference and having the opportunity to connect with industry colleagues. #hVIVO #COVID #Pandemic #COVID19 #pandemicpreparedness #sarscov2

Our Chief Scientific Officer caught up with @brr_mediauk on this weeks announcement on the £7.3M contract. Andrew discusses the importance of #scientificresearch for #influenza & the potential for the next #pandemic. youtu.be/rWL_fEYy3k0 #hVIVO #ORPH #flu #challengestudy

Our Director of #Scientific & #Business Strategy has released the 3rd "Pathogenda" #blog. This edition focuses on the rising cases of #infectiousdiseases, locations of the outbreaks & their potential #threats. Full blog below: hvivo.com/the-pathogenda-inf… #pandemic #polio #virus

Read our recent blog written by Adrian Wildfire, our Director of #Scientific & #Business Strategy. Wildfire's #Infectious #Disease blog: "Pathogenda" discusses the global cycle of infectious diseases, their #pathogens & on-going effects on society hvivo.com/wp-content/uploads… #hVIVO

We are pleased to announce that our Senior Director of Clinical Sciences, Alex Mann, has been invited as a guest speaker at tomorrow's @BSPparasitology in #York. Alex will be discussing challenge agent manufacturing, models & parasites. #ChallengeModels #parasites #hVIVO